Pages that link to "Q67020006"
Jump to navigation
Jump to search
The following pages link to The effect of doxorubicin on hepatic and cardiac glutathione (Q67020006):
Displaying 23 items.
- Doxorubicin cardiomyopathy (Q24606920) (← links)
- Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione (Q28333456) (← links)
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine (Q28366936) (← links)
- Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. (Q33588520) (← links)
- Adriamycin-induced heart failure: mechanism and modulation (Q33963576) (← links)
- Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics (Q35202915) (← links)
- Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo (Q37729274) (← links)
- A review of the use of chemoprotectants in cancer chemotherapy (Q40563060) (← links)
- Comparision of doxorubicin-induced cardiotoxicity in the ICR mice of different sources (Q41125959) (← links)
- P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance. (Q41273129) (← links)
- Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy (Q42538949) (← links)
- The use of 1H spin echo NMR and HPLC to confirm doxorubicin induced depletion of glutathione in the intact HeLa cell (Q43050129) (← links)
- Thymoquinone Ameliorates Doxorubicin-Induced Cardiotoxicity in Swiss Albino Mice by Modulating Oxidative Damage and Cellular Inflammation. (Q54977957) (← links)
- The Role of Active Metabolites in Drug Toxicity (Q56474940) (← links)
- Changes in the cardiac glutathione status after ischemia and reperfusion (Q57312588) (← links)
- Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology (Q64094617) (← links)
- Reduction of daunorubicin in the presence of sulfur-containing peptides (Q67906306) (← links)
- The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat (Q68388166) (← links)
- Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor (Q69908798) (← links)
- Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances (Q71663779) (← links)
- Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen (Q72011914) (← links)
- The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer (Q72149448) (← links)
- Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice (Q92616298) (← links)